| Nadim Habash, MD | |
|
2181 Jamieson Ave Unit 605, Alexandria, VA 22314-5749 | |
| (202) 725-1128 | |
| Not Available |
| Full Name | Nadim Habash |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 2181 Jamieson Ave Unit 605, Alexandria, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699103507 | NPI | - | NPPES |
| MD9344 | Other | DC | DC MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD9344 (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nadim Habash, MD 2181 Jamieson Ave Unit 605, Alexandria, VA 22314-5749 Ph: () - | Nadim Habash, MD 2181 Jamieson Ave Unit 605, Alexandria, VA 22314-5749 Ph: (202) 725-1128 |
News Archive
Delcath Systems, Inc. a development stage, specialty pharmaceutical and medical device company focused on oncology will host a conference call to discuss recent corporate developments on Tuesday, June 15, 2010 at 4:30 p.m., Eastern. Eamonn P. Hobbs, the Company's President and CEO, David McDonald, CFO, and Krishna Kandarpa, MD, Chief Medical Officer, will be on hand during the call and webcast.
The American Optometric Association, the voice of America's family eye doctors, today warned that if a set of U.S. Preventive Services Task Force recommendations are adopted as policy, significant harm will be caused to the ongoing efforts of eye doctors nationwide to reverse the high rates of preventable vision loss in children across America, from the first year of life through age 5.
Researchers from the Royal College of Surgeons in Ireland (RCSI) and Beaumont Hospital have made a breakthrough in understanding the mechanisms behind the most severe form of hereditary emphysema and how protein treatments can improve the condition. The findings of this study may also lead to new treatments for patients with smoker's emphysema.
Protalix BioTherapeutics, Inc., announced today that new clinical data from the switchover trial of taliglucerase alfa in Gaucher disease patients and preclinical data on oral enzyme glucocerebrosidase (oral GCD) will be presented today at the 7th Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2011 in Las Vegas, Nevada.
› Verified 4 days ago
Walter N Wills, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1101 King Street, Suite 100, Lasik Plus Vision Center, Alexandria, VA 22314 Phone: 703-518-8913 | |
Jacob A Clark, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 411 N Washington St, Alexandria, VA 22314 Phone: 703-548-5588 Fax: 703-549-1599 | |
Nicholas Ellyn, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1707 Osage St, Suite 205, Alexandria, VA 22302 Phone: 703-578-0100 Fax: 703-824-8357 | |
Dr. Tofik Mohammed Ali, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6303 Little River Tpke Ste 350, Alexandria, VA 22312 Phone: 571-335-4085 Fax: 571-335-4162 | |
Dr. Steven Redding Bullard, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2865 Duke St, Alexandria, VA 22314 Phone: 703-370-2455 Fax: 703-461-7887 | |
Dr. Gordon A Byrnes, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6354 Walker Ln Ste 100, Suite 502, Alexandria, VA 22310 Phone: 703-313-8822 Fax: 703-313-9422 | |
Dr. Michael B Rivers, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 6355 Walker Ln, Suite 502, Alexandria, VA 22310 Phone: 703-313-8822 Fax: 703-313-9422 |